The invention relates to novel ureas and urethanes of Formula I:
which stimulate cytokine production and may be used to accelerate recovery from neutropenia accompanying radio- or chemotherapy, bone marrow transplantation, or infections. Compounds in the invention or pharmaceutical compositions employing these compounds may be useful in the treatment of cancer, AIDS, aplastic anemia, myelodysplastic syndrome, and infectious diseases, and in the enhancement of immune response.
本发明涉及式 I 的新型
脲和
氨酯:
它们可刺激细胞因子的产生,并可用于加速从伴随放疗或化疗、骨髓移植或感染的中性粒细胞减少症中恢复过来。本发明中的化合物或采用这些化合物的药物组合物可用于治疗癌症、艾滋病、再生障碍性贫血、骨髓增生异常综合症和传染病,以及增强免疫反应。